In 2011, the Centers for Disease Control and Prevention (CDC) published evidence-based guidelines regarding prevention of catheter-related bloodstream infections (CRBSIs). The guidelines highlighted the fact that terminology associated with different
types of bloodstream infections can be confusing because the terms CRBSI and central line–associated bloodstream infections (CLABSI) have often been used interchangeably; however, their definitions are different. A CRBSI is a clinical definition requiring confirmation by laboratory testing, whereas the definition associated with CLABSI is most often used for surveillance.
The National Healthcare Safety Network (NHSN) defines an incidence of CLABSI as “a primary BSI in a patient that had a central line within the 48-hour period before the development of the BSI and is not bloodstream related to an infection at another site.”
Medical adhesive–related skin injury is defined as follows: “A medical adhesive-related skin injury is an occurrence in which erythema and/or other manifestation of cutaneous abnormality (including, but not limited to, vesicle, bulla, erosion, or tear) persists 30 minutes or more after removal of the adhesive.”